Union Health Minister releases first commercial batch of Covaxin

"Released the first commercial batch of COVAXIN from Bharat Biotech's plant at Ankleshwar, Gujarat today. This will increase the supply of vaccine in the country and will help the vaccine reach every Indian," Mandaviya said on social media.

Published On 2021-08-30 05:30 GMT   |   Update On 2021-08-30 12:54 GMT

New Delhi: The Union Health Minister Mansukh Mandaviya on Sunday released the first commercial batch of Covaxin from the new plant of Bharat Biotech at Ankleshwar in Gujarat's Bharuch district. "Vaccination is the most important thing to strengthen the country's fight against coronavirus. Released the first commercial batch of #COVAXIN from Bharat Biotech's plant at Ankleshwar, Gujarat...

Login or Register to read the full article

New Delhi: The Union Health Minister Mansukh Mandaviya on Sunday released the first commercial batch of Covaxin from the new plant of Bharat Biotech at Ankleshwar in Gujarat's Bharuch district.

"Vaccination is the most important thing to strengthen the country's fight against coronavirus. Released the first commercial batch of #COVAXIN from Bharat Biotech's plant at Ankleshwar, Gujarat today. This will increase the supply of vaccine in the country and will help the vaccine reach every Indian," Mandaviya said on social media.

Also Read: DCGI likely to approve Covaxin for kids prior trial period

In May, Bharat Biotech had announced that it planned to produce an additional 200 million doses of Covaxin at its subsidiary Ankleshwar-based facility.

India's vaccination coverage against coronavirus under the mass vaccination drive has crossed the landmark of 63 crore. Over 73 lakh doses have been administered in the last 24 hours.

However, India reported a total of 45,083 new Covid-19 cases and 460 deaths in the last 24 hours, according to the health ministry's data. The active caseload in the country stands at 3,68,558. The surge in daily Covid cases has been driven by a recent spike in Kerala, which accounts for more than half of all the active Covid-19 cases in the country, followed closely by Maharashtra.

Also Read: Bharat Biotech, IVI begin Chikungunya vaccine Phase 2, 3 trial in Costa Rica

Tags:    
Article Source : IANS

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News